Vanessa M. Naimoli

Affiliations: 
sanofi-aventis, St. Louis, MO, United States 
Area:
Neuroscience, psychopharmacology, latent inhibition, behavioral neuroscience, schizophrenia, MATRICS, neurodevelopment, anxiety, depression, circadian biology, immunity, comparative neuroscience
Google:
"Vanessa Naimoli"
Cross-listing: Neurotree

Parents

Sign in to add mentor
Alice Powers grad student St. John's University (Neurotree)
Mark D. Black research scientist sanofi-aventis (Neurotree)
Geoffrey Varty research scientist sanofi-aventis (Neurotree)

Children

Sign in to add trainee
Odile Fabre grad student sanofi-aventis (Neurotree)

Collaborators

Sign in to add collaborator
Ina Weiner collaborator sanofi-aventis (Neurotree)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Griebel G, Pichat P, Boulay D, et al. (2016) The mGluR2 positive allosteric modulator, SAR218645, improves memory and attention deficits in translational models of cognitive symptoms associated with schizophrenia. Scientific Reports. 6: 35320
Naimoli V, Featherstone R, Potestio L, et al. (2015) Compound A, a novel, potent and selective mGluR2 positive allosteric modulator: III. Effects in clinically relevant translational cognition models that could be used as biomarkers F1000research. 4
Rogacki N, Lopez-Grancha M, Naimoli V, et al. (2011) The neurokinin NK2 antagonist, saredutant, ameliorates stress-induced conditions without impairing cognition. Pharmacology, Biochemistry, and Behavior. 98: 405-11
Overstreet DH, Naimoli VM, Griebel G. (2010) Saredutant, an NK2 receptor antagonist, has both antidepressant-like effects and synergizes with desipramine in an animal model of depression. Pharmacology, Biochemistry, and Behavior. 96: 206-10
See more...